SARS-CoV-2 Nucleocapsid Antikörper
-
- Target Alle SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Antikörper anzeigen
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Reaktivität
- SARS Coronavirus-2 (SARS-CoV-2)
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser SARS-CoV-2 Nucleocapsid Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB), Colloidal Gold Immunochromatography Assay (GICA)
- Aufreinigung
- Protein A purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- 2019 nCOV N protein
- Klon
- 3C6
- Isotyp
- IgG1
- Top Product
- Discover our top product SARS-CoV-2 N Primärantikörper
-
-
- Applikationshinweise
- ELISA: Use at an assay dependent concentration(Suggestions: Use a concentration of 0.1 - 1 μg/mL)
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- CB buffer,
- Handhabung
- Avoid repeated freeze / thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
-
Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial." in: Virus research, Vol. 316, pp. 198791, (2022) (PubMed).
: "
-
Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial." in: Virus research, Vol. 316, pp. 198791, (2022) (PubMed).
-
- Target
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
- Andere Bezeichnung
- SARS-CoV-2 Nucleocapsid protein (SARS-CoV-2 N Produkte)
- Synonyme
- nucleocapsid phosphoprotein antikoerper, N antikoerper
- Substanzklasse
- Viral Protein
- Hintergrund
- Synonyms: Background:
- Molekulargewicht
- 48 kDa
-